Susan Amina, MSN, RNC, FNP, has 32 years of experience as a nurse practitioner at Kaiser Permanente in Honolulu, Hawaii, working in internal medicine, health research, infectious disease, nurse practice consultant, and nursing administration and is currently a cancer care coordinator at Kaiser Permanente. She is a nurse advisory committee member to the Regulated Industries Complaints Office in the State of Hawaii. She was a critical care travelling nurse when she accepted her third assignment in Hawaii.

She attended the State University of New York at Binghamton for her master’s degree in the Family Nurse Practitioner program. Ms. Amina earned her undergraduate degree at Alfred University.

Keola K. Beale, MD, is a board-certified hematology and oncology specialist in Honolulu, Hawaii. Dr. Beale was inspired to become an oncologist after losing both his father and grandfather to cancer during his medical training. An avid researcher, he participates in Kaiser Permanente's large oncology clinical trials program. He strives to communicate with his patients in an informative and empathetic manner, treating every patient as he would a loved one.

He received his medical degree at University of California School of Medicine in San Francisco, California.

Michael E. Carney, MD, is a Thomas S. Kosasa Endowed professor and division chief in gynecologic oncology at the John A. Burns School of Medicine and University of Hawaii Cancer Center in Honolulu, Hawaii. He specializes in complex and minimally invasive surgery, treating gynecologic cancers with surgery and chemotherapy, in addition to research including clinical, epidemiologic, and genetic investigations for gynecologic cancers. Dr. Carney is the current president of the Hawaii Society of Clinical Oncology.

A graduate of Loyola University Stritch School of Medicine, he completed his residency in obstetrics and gynecology at Duke University. His fellowship was in gynecologic oncology at Duke University.

Kevin Cassel, DrPH, MPH, is an assistant professor and researcher in the Population Sciences in the Pacific Program at the University of Hawaii Cancer Center, Hawaii. He has over 25 years of experience educating patients with cancer, the public, and health care providers on effective cancer prevention and control strategies. Dr. Cassel uses community-based participatory research methods to help address the critical cancer prevention and control issues of population groups who are experiencing cancer health disparities. His research focus is to adapt and implement proven cancer control interventions with fidelity. Dr. Cassel’s studies have tested the effectiveness of these evidence-based interventions modified for use in resource-limited settings and fitted to suit the unique cultural factors relevant to United States affiliated Pacific Island populations.

Benjamin Falit, MD, JD, is the medical director of the Pacific Cancer Institute and a radiation oncology specialist, in Wailuku, Hawaii. He is trained in the use of novel, more precise radiation delivery techniques, including intensity modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Dr. Falit has published and been an invited speaker on several panels related to health care policy and economics. After residency, Dr. Falit practiced in the greater Boston area as an attending radiation oncologist at Lowell General Hospital and Wentworth Douglass Hospital and joined the Pacific Cancer Institute in 2016. He is also board certified and a diplomat of Radiation Oncology by the American Board of Radiology. 

Dr. Falit received a BA in Psychology from Brandeis University in Waltham, MA, and medical degree from the Yale School of Medicine at Yale University in New Haven, CT. After completing an internship in internal medicine at Yale New Haven Hospital, he trained at the Harvard Radiation Oncology Program in Boston where he saw patients at Massachusetts General Hospital, Dana-Farber Cancer Institute, and Brigham and Women’s Hospital.

Charles F. Miller, MD, FACP, FASCO, is board certified in medical oncology, hematology, and internal medicine and is a Fellow of the American College of Physicians. He served for 30 years in the US Army Medical Department, serving as Commander, 3rd Combat Support Hospital, Nuremberg, Germany and completing his service as the Chief Consultant to the US Army Surgeon General. After retiring from active duty, he completed 9 years as Chief of Hematology-Oncology at Kaiser Medical Center, Honolulu, Hawaii. He has served on the Hawaii Society of Clinical Oncology Board of Directors since 2002 and served as President for seven of those years. He is actively involved at the national level with the American Society of Clinical Oncology, having served on the Clinical Practice Committee, Government Relations Committee, State Affiliate Council, currently serving as Chair, and has actively participated in all ASCO’s Advocacy Summits. He holds a clinical appointment at the University of Hawaii Cancer Center. He has been an active supporter of patient choice for end-of-life care for the people of the state of Hawaii as a member of Doctors for Dignity.

Dr. Miller received his medical degree from the University of Southern California School of Medicine, Los Angeles, California. He completed his residency training at Tripler Army Medical Center Honolulu, Hawaii and fellowship in Hematology-Oncology at Walter Reed Army Medical Center, Washington, DC.

Ian Okazaki, MD, is a hematology oncologist at the Hawaii Pacific Health Straub Medical Center. He also has a clinical practice focused on genitourinary oncology and melanoma. He actively enrolls eligible patients on cooperative group and industry-sponsored clinical trials through the University of Hawaii Cancer Center Consortium.

He received his medical degree from the University of Hawaii John A. Burns School of Medicine and earned his fellowship at University of Minnesota Medical Center in Minneapolis, Minnesota. He completed his residency at the VA Greater Los Angeles Healthcare System in Los Angeles, California and has been in practice in Honolulu, Hawaii for more than 20 years.

Jodi Shaw, LSW, CCM, OSW-C, APHSW-C, is the oncology social worker for Kaiser Permanente Hawaii and one of two patient care coordinators for the Medical Aid in Dying option at Kaiser Permanente Oncology Clinic in Honolulu, Hawaii. She has worked with patients with life-threatening illnesses for 19 years, first at the Hawaii Medical Service Association (Blue Cross/Blue Shield) as a palliative care coordinator and case manager, then since 2008 at Kaiser Permanente Hawaii as a palliative care social worker in the home, inpatient, and clinic settings before becoming Kaiser Hawaii’s first oncology social worker in 2010.

Ms. Shaw received her BA in Asian American Studies at the University of Washington, her MSW degree from the University of Hawaii at Manoa and is board-certified in oncology social work and advanced hospice and palliative social work.

Dr. Stephanie Si Lim, MD, is an assistant professor in pediatric oncology at University of Hawaii Cancer Center and an attending physician at Kapi'olani Women's & Children's Hospital in Honolulu, Hawaii. Her overall research goal is to better understand ethnic disparities within the field of immunotherapy and cancer care disparities within the Hawaiian Islands. Clinically, she is also hoping to introduce chimeric antigen receptor (CAR) T-cell therapy to patients, with the goal of providing the best cancer care to residents of Hawaii.

She graduated from Georgetown University School of Medicine and completed both her residency and fellowship training at the Children's Hospital of Philadelphia.